Clinical trial of Annual SZ drug in Covid-19

Clinical trial of the use of Annual SZ drug in the treatment of patients with Covid-19 disease in Emam Hosein hospital in Tehran.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200607047682N1

Enrollment

Registered

2020-07-27

Start date

2020-06-09

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus not identified

Interventions

Intervention 1: Intervention group: The group treated with Anval SZ + azithromycin Anval S is a herbal product derived from the herb. The active ingredient is artemisinin, which is used in the treatme

Eligibility

Sex/Gender

All

Age

16 Years to 70 Years

Inclusion criteria

Inclusion criteria: pationt infected with covid19

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fever - People who have a fever of more than 38 degrees and their score in the questionnaire is 1 or more than one. Timepoint: At the beginning of the study (before the intervention) and 3, 5, 7, 9, 11, 14 days after the start of use. Method of measurement: Mercury thermometer.;Blood oxygen level 93 and above - People who have a blood oxygen level of less than 93 and get number one in the questionnaire. Timepoint: At the beginning of the study (before the intervention) and 3, 5, 7, 9, 11, 14 days after the start of use. Method of measurement: With digital pulse oximetry device.;Coughs that have a score of one or more in the questionnaire. Timepoint: At the beginning of the study (before the intervention) and 3, 5, 7, 9, 11, 14 days after the start of use. Method of measurement: Based on the follow-up and the patient's report.;CRP that has a score of one or more in the questionnaire. Timepoint: On the day of starting (before treatment) 3, 5, 11 after starting treatment. Method of measurement: With the help of laboratory kit and agglutination method.;HRCT that has a score of one or more based on the questionnaire. Timepoint: The first day before starting treatment and the 30th day after starting treatment. Method of measurement: With the help of CT scan machine.	—

Measure

Time frame

Fever - People who have a fever of more than 38 degrees and their score in the questionnaire is 1 or more than one. Timepoint: At the beginning of the study (before the intervention) and 3, 5, 7, 9, 11, 14 days after the start of use. Method of measurement: Mercury thermometer.;Blood oxygen level 93 and above - People who have a blood oxygen level of less than 93 and get number one in the questionnaire. Timepoint: At the beginning of the study (before the intervention) and 3, 5, 7, 9, 11, 14 days after the start of use. Method of measurement: With digital pulse oximetry device.;Coughs that have a score of one or more in the questionnaire. Timepoint: At the beginning of the study (before the intervention) and 3, 5, 7, 9, 11, 14 days after the start of use. Method of measurement: Based on the follow-up and the patient's report.;CRP that has a score of one or more in the questionnaire. Timepoint: On the day of starting (before treatment) 3, 5, 11 after starting treatment. Method of measurement: With the help of laboratory kit and agglutination method.;HRCT that has a score of one or more based on the questionnaire. Timepoint: The first day before starting treatment and the 30th day after starting treatment. Method of measurement: With the help of CT scan machine.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Chegini

Islamic Azad University

H.chegini2010@yahoo.com0098 42518000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026